Nov 9, 2017

Creoptix Enters UK Market with Mologic

The WAVE lands in Bedford Technology Park, United Kingdom

A new WAVE is installed!

Creoptix announces entering UK market with Mologic as first customer and providing new research avenues for their Centre for Advanced Rapid Diagnostics (“CARD”).

Dr James Schouten, Lead Scientist in Mologic’s CARD team, said “Understanding the dynamics of our detection reagents in complex matrices presents a big challenge when developing new assay platforms, particularly as we advance the limits of sensitivity with novel amplification technologies. The WAVEdelta system opens up new exciting opportunities for the project by giving us a real-time view of these interactions. The impressive detection range and versatility of the system will be a huge asset as the project progresses.”